ZTS Zoetis Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

ZTS [NYSE]

Zoetis Inc.

Healthcare | Drug Manufacturers - Specialty & Generic | USA

statements

Index	S&P 500	P/E	46.89	EPS (ttm)	3.38	Insider Own	0.25%	Shs Outstand	475.30M	Perf Week	-3.02%
Market Cap	76.59B	Forward P/E	38.03	EPS next Y	4.17	Insider Trans	-5.26%	Shs Float	474.67M	Perf Month	-3.34%
Income	1.62B	PEG	5.06	EPS next Q	0.91	Inst Own	94.30%	Short Float	0.84%	Perf Quarter	2.61%
Sales	6.34B	P/S	12.08	EPS this Y	9.60%	Inst Trans	0.09%	Short Ratio	2.55	Perf Half Y	24.41%
Book/sh	6.27	P/B	25.29	EPS next Y	14.63%	ROA	13.60%	Target Price	175.64	Perf Year	23.94%
Cash/sh	-	P/C	-	EPS next 5Y	9.27%	ROE	58.20%	52W Range	90.14 - 168.96	Perf YTD	19.80%
Dividend	0.80	P/FCF	69.06	EPS past 5Y	21.80%	ROI	16.40%	52W High	-6.16%	Beta	0.73
Dividend %	0.50%	Quick Ratio	2.60	Sales past 5Y	5.50%	Gross Margin	70.00%	52W Low	75.89%	ATR	3.59
Employees	10600	Current Ratio	3.50	Sales Q/Q	0.10%	Oper. Margin	30.70%	RSI (14)	42.99	Volatility	2.60% 2.06%
Optionable	Yes	Debt/Eq	2.58	EPS Q/Q	2.50%	Profit Margin	25.50%	Rel Volume	1.31	Prev Close	161.19
Shortable	Yes	LT Debt/Eq	2.41	Earnings	Nov 05 BMO	Payout	21.40%	Avg Volume	1.57M	Price	158.55
Recom	2.00	SMA20	-2.45%	SMA50	-1.58%	SMA200	12.10%	Volume	2,054,046	Change	-1.64%

Sep-21-20

Initiated

Atlantic Equities

Overweight

$191

Aug-14-20

Upgrade

Edward Jones

Hold → Buy

Aug-12-20

Downgrade

Gabelli & Co

Buy → Hold

May-27-20

Initiated

Jefferies

Buy

$152

Jan-10-20

Initiated

Raymond James

Mkt Perform

Sep-09-19

Initiated

Goldman

Buy

$145

Jul-01-19

Downgrade

BofA/Merrill

Buy → Neutral

$111 → $120

Jun-11-19

Initiated

Barclays

Overweight

$120

May-23-19

Initiated

Guggenheim

Buy

$114

May-03-19

Downgrade

Gabelli & Co

Buy → Hold

$108

Mar-20-19

Initiated

SunTrust

Hold

Mar-04-19

Upgrade

Stifel

Hold → Buy

$97 → $110

Jan-23-19

Initiated

UBS

Neutral

$86

Oct-15-18

Upgrade

JP Morgan

Neutral → Overweight

Aug-22-18

Downgrade

Stifel

Buy → Hold

$95

Aug-03-18

Reiterated

Stifel

Buy

$86 → $95

Apr-19-18

Reiterated

Citigroup

Buy

$85 → $98

Mar-19-18

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Feb-16-18

Reiterated

Stifel

Buy

$84 → $86

Jan-04-18

Upgrade

Citigroup

Neutral → Buy

Oct-30-20 12:57PM	Pacira's (PCRX) Q3 Earnings Top Estimates, Revenues Rise Y/Y Zacks
Oct-28-20 11:40AM	GRFS vs. ZTS: Which Stock Is the Better Value Option? Zacks
Oct-26-20 02:08PM	The Zacks Analyst Blog Highlights: Netflix, Lockheed, Zoetis, ITUB and Moderna Zacks
08:30AM	Zoetis to Participate in the Credit Suisse 2020 Virtual Healthcare Conference Business Wire
Oct-23-20 04:06PM	Top Analyst Reports for Netflix, Lockheed Martin & Zoetis Zacks
Oct-21-20 12:03PM	Were Hedge Funds Right About Crowding Into Zoetis Inc (ZTS)? Insider Monkey
Oct-16-20 11:30AM	Is Zoetis (ZTS) Stock Outpacing Its Medical Peers This Year? Zacks
Oct-14-20 12:10PM	Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again Zacks
09:01AM	Pharma Stocks Poised to Move Higher Investopedia
Oct-07-20 04:33PM	Zoetis Declares Fourth Quarter 2020 Dividend Business Wire
Oct-05-20 11:40AM	JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
Sep-30-20 08:30AM	Zoetis to Host Webcast and Conference Call on Third Quarter 2020 Financial Results Business Wire
Sep-23-20 02:10PM	If You Like EPS Growth Then Check Out Zoetis (NYSE:ZTS) Before It's Too Late Simply Wall St.
Sep-17-20 11:40AM	JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
Sep-15-20 08:00PM	The Argus Dividend Growth Portfolio Argus Research
06:14PM	Analyst Report: Zoetis Inc. Morningstar Research
10:40AM	Zoetis Named a Top Company for Working Mothers Business Wire
Sep-13-20 08:00PM	Weekly Stock List Argus Research
Sep-11-20 09:04AM	Zoetis is Higher Than Ever Thanks to Pet (and Farm) Spending InvestorPlace
Sep-10-20 08:30AM	Zoetis to Participate in the 18th Annual Morgan Stanley Healthcare Conference Business Wire
Sep-08-20 07:04PM	Analyst Report: Zoetis Inc. Morningstar Research
Sep-05-20 11:31AM	Why Is Zoetis (ZTS) Down 2.5% Since Last Earnings Report? Zacks
Sep-04-20 04:28PM	'Halftime Report' Share Their Thoughts On Zoetis, General Motors And Trex Benzinga
Sep-02-20 09:10AM	This Pet Stock Just Bought an Animal Health Business for $7.6 Billion Motley Fool
Sep-01-20 11:40AM	JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
08:10AM	How This Animal Health Company Was Disrupted by the Coronavirus Motley Fool
Aug-31-20 01:25PM	Do Hedge Funds Love Zoetis Inc (ZTS)? Insider Monkey
Aug-28-20 11:02AM	Zoetis Near Tight Entry Investor's Business Daily Video
Aug-21-20 03:51AM	Zoetis Price Target Raised to $167 on Strong Companion Animal Trends, $203 in Best-Case Scenario: Morgan Stanley FX Empire
Aug-14-20 05:39PM	The Economy May Be Struggling, but the Pet Business and the Stock Market Keep Running Strong Barrons.com
Aug-13-20 03:04AM	Gabelli Cuts Zoetis To Hold On Valuation SmarterAnalyst
Aug-06-20 04:07PM	Zoetis Earnings, Full-Year Outlook Beat Expectations; ZTS Stock Jumps Investor's Business Daily
11:31AM	Zoetis' (ZTS) Q2 Earnings and Revenues Surpass Estimates Zacks
08:45AM	Zoetis (ZTS) Q2 Earnings and Revenues Beat Estimates Zacks
07:00AM	Zoetis Announces Second Quarter 2020 Results Business Wire
Jul-30-20 12:33PM	Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Jul-21-20 12:10PM	Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report? Zacks
09:15AM	Zoetis (ZTS) Hits 52-Week High, Can the Run Continue? Zacks
Jul-18-20 08:09AM	Is Elanco Stock a Buy? Motley Fool
Jul-17-20 11:05AM	Dow Holds 650-Point Weekly Gain; Why Ericsson, Wingstop, Zoetis Hit Buy Points Today Investor's Business Daily
Jul-10-20 08:06AM	DYAI: Dyadic Animal Health Partners Summary Zacks Small Cap Research
Jul-08-20 01:25PM	Were Hedge Funds Right About Zoetis Inc (ZTS)? Insider Monkey
Jul-07-20 07:06AM	Trianni and Zoetis Announce Agreement to Develop a Transgenic Antibody Discovery Platform for Use in Animal Health PR Newswire
Jun-26-20 08:30AM	Zoetis to Host Webcast and Conference Call on Second Quarter 2020 Financial Results Business Wire
Jun-08-20 10:41AM	Tailoring Portfolios to Coronavirus and Recession GuruFocus.com
08:30AM	Zoetis to Participate in the William Blair 40th Annual Growth Stock Conference Business Wire
Jun-05-20 11:32AM	Zoetis (ZTS) Up 13.1% Since Last Earnings Report: Can It Continue? Zacks
08:14AM	Edited Transcript of ZTS earnings conference call or presentation 6-May-20 12:30pm GMT Thomson Reuters StreetEvents
Jun-03-20 10:00AM	Why These 5 Pharma Stocks Are Outplaying 90% Of The Stock Market Investor's Business Daily
May-29-20 01:01PM	The InvestorPlace Q&A: ProShares Pet Care ETF Is a Treat for Investors InvestorPlace
May-26-20 03:20PM	Hedge Funds Were Piling Into Zoetis Inc (ZTS) During The Pandemic Crash Insider Monkey
May-22-20 11:40AM	PCRX vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
May-20-20 04:30PM	Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2020 Dividend Business Wire
May-19-20 08:10PM	Why Pet Stocks Are an Investor Treat Motley Fool
May-18-20 08:30AM	Zoetis to Participate in the Stifel 2020 Virtual Jaws & Paws Conference Business Wire
May-11-20 01:23PM	Top Research Reports for Amgen, BHP, Altria & Others Zacks
May-07-20 08:45PM	Zoetis Announces Pricing of $1.25 Billion of Senior Notes Business Wire
11:29AM	Zoetis Inc. -- Moody's assigns Baa1 rating to Zoetis' new senior unsecured notes offering; outlook stable Moody's
May-06-20 04:23PM	Why Fido's Drugmaker Says Its First-Quarter Luck Is About To Run Out Investor's Business Daily
03:32PM	Zoetis Inc (ZTS) Q1 2020 Earnings Call Transcript Motley Fool
01:56PM	Zoetis Beats Expectations in Q1 but Lowers Full-Year Outlook Due to COVID-19 Motley Fool
01:22PM	Zoetis' (ZTS) Q1 Earnings Beat Estimates, Revenues In Line Zacks
11:23AM	Animal-Care Company Zoetis Had a Solid First Quarter. It Expects to Take a Hit in the Next Quarter. Barrons.com
08:35AM	Zoetis (ZTS) Q1 Earnings and Revenues Top Estimates Zacks
07:00AM	Zoetis Announces First Quarter 2020 Results Business Wire
May-05-20 11:45AM	Drug/Biotech Stock Q1 Earnings Due on May 6: ZTS, ALXN & More Zacks
May-04-20 01:36PM	Eaton Vance Worldwide Health Sciences Fund Adds 3 Stocks to Portfolio GuruFocus.com
01:34PM	Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-30-20 04:29PM	Wall Street Declines on Thursday GuruFocus.com
08:01AM	Innovative New Pet Health Start-up, Pumpkin Insurance Services, Launches in the U.S. Business Wire
Apr-29-20 12:33PM	Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy? Zacks
06:10AM	Three High-Quality Companies To Bet On In A Post-Coronavirus World Benzinga
Apr-27-20 12:10PM	Can Zoetis (ZTS) Keep the Earnings Surprise Streak Alive? Zacks
11:40AM	GRFS vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Apr-22-20 03:36PM	How the $484B stimulus bill will impact the healthcare sector Yahoo Finance Video
11:06AM	What Is Zoetis's (NYSE:ZTS) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
Apr-19-20 08:30AM	Masters of the Spare Bedroom: How Fund Managers See The World While They Work From Home Barrons.com
Apr-17-20 04:30PM	Zoetis Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation Business Wire
Apr-09-20 11:40AM	GRFS vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
10:23AM	The Zacks Analyst Blog Highlights: Tesla, Zoetis, Target, Boston Scientific and Moody's Zacks
Apr-08-20 03:23PM	Top Research Reports for Tesla, Zoetis, Target Zacks
Apr-06-20 10:38AM	No Baseball, but My 30-30 Club Continues GuruFocus.com +10.63%
Apr-01-20 08:30AM	Zoetis to Host Webcast and Conference Call on First Quarter 2020 Financial Results Business Wire
Mar-27-20 04:18PM	IBD Stock Of The Day: How Fido's Drugmaker Is Shielded From Covid Volatility Investor's Business Daily -5.21%
Mar-24-20 04:19PM	Fluffy's Drugmakers Are Insulated From Coronavirus But For How Long? Investor's Business Daily +11.98%
Mar-22-20 11:03AM	Three stocks that are part of the solution to the coronavirus crisis MarketWatch
Mar-17-20 02:04PM	Top Pharmaceutical Stocks for Q2 2020 Investopedia
Mar-16-20 09:40PM	Zoetis Inc (ZTS): Are Hedge Funds Right About This Stock? Insider Monkey -14.70%
Mar-15-20 04:06PM	Weekly CFO Sells Highlight GuruFocus.com
Mar-14-20 11:30AM	Zoetis (ZTS) Down 13.4% Since Last Earnings Report: Can It Rebound? Zacks
Mar-13-20 11:40AM	PCRX or ZTS: Which Is the Better Value Stock Right Now? Zacks
Mar-12-20 01:03PM	Zoetis Looks Like a Nice Pet Project for Investors, Just Not Yet TheStreet.com -7.67%
Mar-05-20 08:00AM	Zoetis' First CEO Shows You How To Thrive On Your Own Investor's Business Daily
Mar-04-20 11:10AM	IDEXX Laboratories: A Widening Moat and a Massive Runway Ahead GuruFocus.com
11:00AM	These 4 Pharma Stocks Are Outplaying 90% Of The Stock Market Investor's Business Daily
Mar-03-20 10:55AM	Zoetis Named a Top Company for Executive Women by NAFE Business Wire
Feb-27-20 03:41PM	Zoetis Won U.S. Approval for a Dog Pill. Thats Why Its Stock Is Holding Up During the Rout. Barrons.com
02:00PM	Zoetis Receives FDA Approval for Simparica Trio, A New Combination Parasite Preventative for Dogs Business Wire
Feb-26-20 11:40AM	PCRX vs. ZTS: Which Stock Is the Better Value Option? Zacks
Feb-21-20 08:30AM	Zoetis to Participate in the Cowen and Company 40th Annual Health Care Conference Business Wire

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chen Heidi C.	Executive Vice President	Oct 01	Option Exercise	41.83	1,179	49,318	17,514	Oct 02 06:04 PM
Trawicki Roman	Executive Vice President	Oct 01	Option Exercise	55.02	4,080	224,482	5,501	Oct 02 06:08 PM
Chen Heidi C.	Executive Vice President	Oct 01	Sale	166.23	1,179	195,985	16,335	Oct 02 06:04 PM
Trawicki Roman	Executive Vice President	Oct 01	Sale	166.03	5,501	913,353	0	Oct 02 06:08 PM
Rhodes Linda	Director	Sep 04	Sale	159.16	1,087	173,007	1,468	Sep 08 04:18 PM
Chen Heidi C.	Executive Vice President	Sep 01	Option Exercise	41.83	1,179	49,318	17,514	Sep 02 04:48 PM
Chen Heidi C.	Executive Vice President	Sep 01	Sale	160.71	1,179	189,477	16,335	Sep 02 04:48 PM
PECK KRISTIN C	Chief Executive Officer	Aug 25	Option Exercise	30.89	6,500	200,785	42,374	Aug 26 06:00 PM
PECK KRISTIN C	Chief Executive Officer	Aug 25	Sale	157.61	10,500	1,654,889	31,874	Aug 26 06:00 PM
Lagano Roxanne	Executive Vice President	Aug 19	Option Exercise	41.83	6,000	250,980	41,680	Aug 21 04:27 PM
Lagano Roxanne	Executive Vice President	Aug 19	Sale	160.37	6,000	962,220	35,680	Aug 21 04:27 PM
Knupp Catherine A.	Executive Vice President	Aug 13	Sale	158.86	13,000	2,065,160	50,368	Aug 17 04:26 PM
Reed Willie M	Director	Aug 13	Sale	159.07	1,885	299,847	4,635	Aug 17 04:23 PM
Chen Heidi C.	Executive Vice President	Aug 03	Option Exercise	41.83	1,179	49,318	17,514	Aug 04 04:31 PM
Chen Heidi C.	Executive Vice President	Aug 03	Sale	152.19	1,179	179,432	16,335	Aug 04 04:31 PM
Chen Heidi C.	Executive Vice President	Jul 01	Option Exercise	41.83	1,179	49,318	17,514	Jul 02 06:13 PM
Trawicki Roman	Executive Vice President	Jul 01	Option Exercise	55.02	4,079	224,427	6,920	Jul 02 06:18 PM
Chen Heidi C.	Executive Vice President	Jul 01	Sale	137.29	1,179	161,865	16,335	Jul 02 06:13 PM
Trawicki Roman	Executive Vice President	Jul 01	Sale	137.29	5,499	754,958	1,421	Jul 02 06:18 PM
Chen Heidi C.	Executive Vice President	Jun 01	Option Exercise	41.83	1,179	49,318	17,514	Jun 02 04:18 PM
Chen Heidi C.	Executive Vice President	Jun 01	Sale	138.65	1,179	163,468	16,335	Jun 02 04:18 PM
PECK KRISTIN C	Chief Executive Officer	May 26	Option Exercise	27.97	6,500	181,787	46,374	May 28 04:29 PM
PECK KRISTIN C	Chief Executive Officer	May 26	Sale	131.31	10,500	1,378,783	35,874	May 28 04:29 PM
Lagano Roxanne	Executive Vice President	May 19	Option Exercise	46.09	4,463	205,700	40,143	May 21 04:19 PM
Lagano Roxanne	Executive Vice President	May 19	Sale	131.02	4,463	584,742	35,680	May 21 04:19 PM
Chen Heidi C.	Executive Vice President	May 01	Option Exercise	41.83	1,179	49,318	17,514	May 04 04:49 PM
Chen Heidi C.	Executive Vice President	May 01	Sale	127.44	1,179	150,252	16,335	May 04 04:49 PM
Trawicki Roman	Executive Vice President	Apr 07	Option Exercise	55.02	4,079	224,427	8,340	Apr 07 04:24 PM
Trawicki Roman	Executive Vice President	Apr 07	Sale	130.00	5,499	714,870	2,841	Apr 07 04:24 PM
Chen Heidi C.	Executive Vice President	Apr 06	Option Exercise	41.83	1,179	49,318	17,514	Apr 07 04:21 PM
Chen Heidi C.	Executive Vice President	Apr 06	Sale	120.00	1,179	141,480	16,335	Apr 07 04:21 PM
David Glenn	Chief Financial Officer	Mar 05	Option Exercise	53.80	43,778	2,355,174	69,519	Mar 06 05:19 PM
David Glenn	Chief Financial Officer	Mar 05	Sale	140.89	43,778	6,167,794	25,741	Mar 06 05:19 PM
Alaix Juan Ramon	Director	Mar 04	Option Exercise	52.12	218,208	11,372,091	314,221	Mar 05 04:26 PM
Alaix Juan Ramon	Director	Mar 04	Sale	141.38	218,208	30,850,451	96,013	Mar 05 04:26 PM
Alaix Juan Ramon	Director	Mar 03	Option Exercise	41.83	45,452	1,901,257	141,465	Mar 05 04:26 PM
Alaix Juan Ramon	Director	Mar 03	Sale	140.66	45,452	6,393,059	96,013	Mar 05 04:26 PM
Chen Heidi C.	Executive Vice President	Mar 02	Option Exercise	41.83	1,179	49,318	17,514	Mar 03 04:35 PM
Chen Heidi C.	Executive Vice President	Mar 02	Sale	134.30	1,179	158,340	16,335	Mar 03 04:35 PM
PECK KRISTIN C	Chief Executive Officer	Feb 25	Option Exercise	26.00	6,500	169,000	51,799	Feb 26 04:22 PM
PECK KRISTIN C	Chief Executive Officer	Feb 25	Sale	138.10	11,925	1,646,787	39,874	Feb 26 04:22 PM
Alaix Juan Ramon	Director	Feb 21	Option Exercise	42.76	120,353	5,145,906	216,366	Feb 24 04:14 PM
Alaix Juan Ramon	Director	Feb 21	Sale	142.32	120,353	17,128,639	96,013	Feb 24 04:14 PM
Alaix Juan Ramon	Director	Feb 20	Option Exercise	46.09	20,725	955,215	116,738	Feb 21 04:22 PM
Alaix Juan Ramon	Director	Feb 20	Sale	143.61	20,725	2,976,317	96,013	Feb 21 04:22 PM
Lagano Roxanne	Executive Vice President	Feb 19	Option Exercise	46.09	4,463	205,700	40,143	Feb 20 04:22 PM
Trawicki Roman	Executive Vice President	Feb 19	Option Exercise	55.02	4,079	224,427	9,760	Feb 20 04:26 PM
Alaix Juan Ramon	Director	Feb 19	Option Exercise	46.09	63,046	2,905,790	159,059	Feb 21 04:22 PM
Alaix Juan Ramon	Director	Feb 19	Sale	144.03	63,046	9,080,577	96,013	Feb 21 04:22 PM
Lagano Roxanne	Executive Vice President	Feb 19	Sale	143.41	4,463	640,039	35,680	Feb 20 04:22 PM
Trawicki Roman	Executive Vice President	Feb 19	Sale	143.42	5,499	788,667	4,261	Feb 20 04:26 PM
Chen Heidi C.	Executive Vice President	Feb 19	Sale	143.41	3,289	471,675	16,335	Feb 20 04:18 PM
Chen Heidi C.	Executive Vice President	Feb 03	Option Exercise	41.83	1,179	49,318	12,642	Feb 04 06:07 PM
Chen Heidi C.	Executive Vice President	Feb 03	Sale	134.58	1,179	158,670	11,463	Feb 04 06:07 PM
Chen Heidi C.	Executive Vice President	Jan 21	Option Exercise	41.83	15,329	641,212	26,792	Jan 23 04:48 PM
Chen Heidi C.	Executive Vice President	Jan 21	Sale	139.81	15,329	2,143,115	11,463	Jan 23 04:48 PM
Trawicki Roman	Executive Vice President	Jan 15	Sale	137.41	2,199	302,165	0	Jan 16 05:03 PM
Lewis Clinton A. Jr.	Executive Vice President	Dec 16	Option Exercise	26.00	3,566	92,716	34,027	Dec 18 04:34 PM
Lewis Clinton A. Jr.	Executive Vice President	Dec 16	Sale	124.93	6,123	764,946	27,904	Dec 18 04:34 PM
David Glenn	Chief Financial Officer	Dec 03	Option Exercise	51.23	16,861	863,789	29,149	Dec 04 04:31 PM
David Glenn	Chief Financial Officer	Dec 03	Sale	120.17	16,861	2,026,186	12,288	Dec 04 04:31 PM
David Glenn	Chief Financial Officer	Dec 02	Option Exercise	51.23	4,440	227,461	16,728	Dec 04 04:31 PM
David Glenn	Chief Financial Officer	Dec 02	Sale	120.02	4,440	532,889	12,288	Dec 04 04:31 PM
Knupp Catherine A.	Executive Vice President	Nov 27	Option Exercise	46.09	28,563	1,316,469	78,616	Dec 02 04:25 PM
Knupp Catherine A.	Executive Vice President	Nov 27	Sale	121.37	28,563	3,466,792	50,053	Dec 02 04:25 PM
Chen Heidi C.	Executive Vice President	Nov 21	Option Exercise	46.09	11,425	526,578	22,888	Nov 25 05:07 PM
Fenton Andrew	Executive Vice President	Nov 21	Sale	120.30	12,705	1,528,412	21,530	Nov 25 05:20 PM
Chen Heidi C.	Executive Vice President	Nov 21	Sale	119.67	11,425	1,367,230	11,463	Nov 25 05:07 PM
Lagano Roxanne	Executive Vice President	Nov 19	Option Exercise	46.09	4,463	205,700	33,190	Nov 20 04:30 PM
Alaix Juan Ramon	Chief Executive Officer	Nov 19	Option Exercise	46.09	50,000	2,304,500	146,013	Nov 20 04:46 PM
Lagano Roxanne	Executive Vice President	Nov 19	Sale	118.99	4,463	531,052	28,727	Nov 20 04:30 PM
Alaix Juan Ramon	Chief Executive Officer	Nov 19	Sale	119.13	50,000	5,956,500	96,013	Nov 20 04:46 PM
Chen Heidi C.	Executive Vice President	Nov 18	Option Exercise	46.09	11,425	526,578	22,888	Nov 20 04:16 PM
Chen Heidi C.	Executive Vice President	Nov 18	Sale	118.86	11,425	1,357,976	11,463	Nov 20 04:16 PM
Lewis Clinton A. Jr.	Executive Vice President	Nov 14	Option Exercise	26.00	3,566	92,716	36,584	Nov 15 04:13 PM
Lewis Clinton A. Jr.	Executive Vice President	Nov 14	Sale	116.13	6,123	711,064	30,461	Nov 15 04:13 PM
PECK KRISTIN C	Executive Vice President	Nov 12	Option Exercise	26.00	7,500	195,000	44,877	Nov 14 05:17 PM
PECK KRISTIN C	Executive Vice President	Nov 12	Sale	117.16	11,500	1,347,390	33,377	Nov 14 05:17 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience